Discover
PLSE
Pulse Biosciences, Inc.
32.48
1 x 31.93
1 x 32.10
bid
ask
+
2.22
7.34%
12:05 PM
timesize
| Ytd | 136.56% | |
| 1y | 114.25% |
29.71
day range
32.58
12.56
52 week range
31.00
| Open | 30.43 | Prev Close | 30.26 | Low | 29.71 | High | 32.58 | Mkt Cap | 2.09B |
| Vol | 143.73K | Avg Vol | 339.94K | EPS | -1.10 | P/E | -27.51 | Forward P/E | -24.12 |
| Beta | 1.65 | Short Ratio | 7.50 | Inst. Own | 11.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 26.00 | 200-d Avg | 19.79 | 1yr Est | 30.67 |
| Income Statement | |||
| Total Revenue | 401.00K | ||
| Revenues (USD) | 401.00K | ||
| Cost of Revenue | 370.00K | ||
| Gross Profit | 31.00K | ||
| Operating Expenses | 19.18M | ||
| Research and Development Expense | 12.59M | ||
| Selling, General and Administrative Expense | 6.59M | ||
| Operating Income | -19.15M | ||
| Net Income | -18.58M | ||
| Net Income Common Stock | -18.58M | ||
| Net Income Common Stock (USD) | -18.58M | ||
| Consolidated Income | -18.58M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -18.58M | ||
| Earning Before Interest & Taxes (USD) | -18.58M | ||
| Weighted Average Shares | 67.99M | ||
| Weighted Average Shares Diluted | 67.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 68.32M | ||
| Cash and Equivalents (USD) | 68.32M | ||
| Trade and Non-Trade Receivables | 157.00K | ||
| Current Assets | 71.13M | ||
| Property, Plant & Equipment Net | 6.72M | ||
| Total Assets | 81.62M | ||
| Debt Current | 1.63M | ||
| Total Debt | 7.16M | ||
| Current Liabilities | 9.80M | ||
| Debt Non-Current | 5.53M | ||
| Total Liabilities | 15.32M | ||
| Accumulated Retained Earnings (Deficit) | -481.86M | ||
| Shareholders Equity | 66.30M | ||
| Shareholders Equity (USD) | 66.30M | ||
| Assets Non-Current | 10.49M | ||
| Total Debt (USD) | 7.16M | ||
| Goodwill and Intangible Assets | 3.20M | ||
| Inventory | 206.00K | ||
| Liabilities Non-Current | 5.53M | ||
| Trade and Non-Trade Payables | 2.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 563.00K | ||
| Net Cash Flow from Financing | 2.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.42M | ||
| Capital Expenditure | -33.00K | ||
| Issuance (Purchase) of Equity Shares | 2.27M | ||
| Net Cash Flow from Investing | -33.00K | ||
| Net Cash Flow from Operations | -14.59M | ||
| Share Based Compensation | 1.91M | ||